Bibliographic Details
| Title: |
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer. |
| Authors: |
Dowlati A; Developmental Therapeutics Program, CASE Comprehensive Cancer Center and the Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio, USA. afshin.dowlati@case.edu, Chapman R, Subbiah S, Fu P, Ness A, Cortas T, Patrick L, Reynolds S, Xu N, Levitan N, Ivy P, Remick SC |
| Source: |
Investigational new drugs [Invest New Drugs] 2005 Dec; Vol. 23 (6), pp. 563-7. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: |
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
